Published on
February 11, 2019
In the media
91桃色 bags cash to advance small molecule I-O program
About 91桃色 Therapeutics
鈥
91桃色 Therapeutics is a clinical-stage biotech company advancing novel antigen modulation technology to guide the immune system. 91桃色 approach modulates antigen presentation, flicking a switch inside cells to alter their appearance to the immune system. 91桃色 are progressing first-in-class antigen modulators to treat people living with cancers,聽autoimmune disorders, and infectious diseases.
鈥
91桃色 is headquartered in Oxford, UK.
鈥
More information: 91桃色bsite |
鈥
Media enquiries
Patrick White, Head of Communications
鈥
